Peptinovo Biopharma Inc. is raising up to $124K on Silicon Prairie Capital Partners, LLC in preferred stock at $3.38533 each; in its filing revenue was $3K and it had 4 employees (Form C-AR, 2026-09-02).
Peptinovo Biopharma Inc. filed a Regulation Crowdfunding offering with the SEC through Silicon Prairie Capital Partners, LLC, with a target of $50K and a maximum of $124K. As of November 6, 2026, the offering is past its deadline of September 22, 2026. The company gives its address as Ann Arbor, MI (Form C/A, August 20, 2026).
Sell to companies like Peptinovo Biopharma Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · What it is: Reporting ended · C-TR
- · What it is: Annual report · C-AR
- · What it is: Progress update · C-U
- · Intermediary: Silicon Prairie Capital Partners, LLC · Target: $50K · Maximum: $124K · Deadline: 2026-09-22 · Security: Preferred Stock · C/A
- · Intermediary: Silicon Prairie Capital Partners, LLC · Target: $50K · Maximum: $124K · Deadline: 2026-09-22 · Security: Preferred Stock · C/A
Peptinovo Biopharma Inc., based in Ann Arbor, MI, filed 5 Regulation Crowdfunding offering filings with the SEC, the latest on 2026-08-20, raising through Silicon Prairie Capital Partners, LLC. It set a target of $50K and will accept up to $124K. The security offered is preferred stock at $3.38533 each. As of its filings the offering is past its deadline of 2026-09-22. 8 filings in this family are on record for the company.
Terms at a glance
| Target | $50K |
| Maximum it will accept | $124K |
| Security | Preferred Stock |
| Price per unit | $3.38533 |
| Units at the target | 14,769 |
| Raise above the target | accepted, first-come, first-served basis |
| Deadline | 2026-09-22 |
| Raising through | Silicon Prairie Capital Partners, LLC |
| What the portal is paid, as filed | $66,000 if the maximum amount is raised. |
Check before you invest in Peptinovo Biopharma Inc.: who signed the filing and its own figures, free.
Free to see. No signup.
Want the whole picture on Peptinovo Biopharma Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Peptinovo Biopharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Peptinovo Biopharma Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
The filing does not state a company valuation or a minimum investment; the offering page on Silicon Prairie Capital Partners, LLC shows those. Check both before you invest.
Money raised before
Earlier raises by this company that are on file, with the amounts as filed. A figure for a raise is what the company reported, not a check of what it received.
| Filed | What | Amount as filed | Filing |
|---|---|---|---|
| 2024-12-16 | Private placement (Form D amendment) | $1.30M sold of $10M offered | filing |
| 2024-09-24 | Private placement (Form D) | $1.32M sold of $10M offered | filing |
Offering filings
| Filed | Intermediary | Target | Maximum | Deadline | Security | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Silicon Prairie Capital Partners, LLC | $50K | $124K | 2026-09-22 | Preferred Stock | C/A |
| 2025-10-02 | Silicon Prairie Capital Partners, LLC | $50K | $124K | 2026-09-22 | Preferred Stock | C/A |
| 2025-09-04 | Silicon Prairie Capital Partners, LLC | $50K | $1.25M | 2025-09-04 | Preferred Stock | C/A |
| 2025-03-10 | Silicon Prairie Capital Partners, LLC | $50K | $1.25M | 2025-09-04 | Preferred Stock | C/A |
| 2025-03-05 | Silicon Prairie Capital Partners, LLC | $50K | $1.25M | 2025-09-04 | Preferred Stock | C |
Financials the company filed
Figures from the C-AR filed 2026-09-02, as the company reported them.
| As filed | Most recent fiscal year | Prior fiscal year |
|---|---|---|
| Revenue | $3K | $2K |
| Net income | -$5.60M | -$4.80M |
| Total assets | $1.62M | $3.06M |
| Cash and equivalents | $137K | |
| Short-term debt | $7.95M | |
| Long-term debt | $0 |
Employees at filing: 4.
Revenue went from $2K to $3K (+4%). Net loss was $5.60M, against a loss of $4.80M the year before. It reported $137K in cash and $7.95M in debt. These are the company's own figures from the Form C-AR filed 2026-09-02.
Progress updates
2026-08-31, C-U:
$81,000.00 has been raised to date.
People who signed the filing
- Ren Homan, PRESIDENT AND DIRECTOR
- Steve Tokarz, CEO AND DIRECTOR
- Fred Brown, DIRECTOR
- David Romenesko, DIRECTOR
- Michael Mortlock, DIRECTOR
Every filing
| Filed | What it is | Filing |
|---|---|---|
| 2026-09-03 | Reporting ended | C-TR |
| 2026-09-02 | Annual report | C-AR |
| 2026-08-31 | Progress update | C-U |
| 2026-08-20 | Offering amended | C/A |
| 2025-10-02 | Offering amended | C/A |
| 2025-09-04 | Offering amended | C/A |
| 2025-03-10 | Offering amended | C/A |
| 2025-03-05 | Offering | C |
What to check before investing
- Read the offering page on Silicon Prairie Capital Partners, LLC: it states the valuation or cap and the minimum investment, which the SEC filing does not.
- Compare the terms above with the numbers: what does the price imply against revenue of $3K?
- Look at who signed the filing and what else they have run (the founder Snapshot below).
- Check the deadline and what happens if the target is missed.
- You cannot easily sell a crowdfunding security; invest only what you can leave tied up.
A crowdfunding round is won in public. FoxPlug turns your commits, deploys and releases into the posts and visuals that keep the story moving while the offering is open.
Build your launch kitRun a Snapshot on Ren Homan: other companies, roles and the record behind them. Order Full Report from there if you need more.
Snapshot the foundersTools for this story
Each opens in a new tab, filled in for Peptinovo Biopharma Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A company raising money from the public under Regulation Crowdfunding has to file with the SEC before the offering opens, and has to raise through a single registered intermediary: a funding portal or a broker-dealer. The first filing, Form C, states how much the company is trying to raise, the most it will accept, the deadline, the security and its price, the intermediary and what the intermediary is paid, and two years of the company's own financial figures.
After that the company files amendments when terms change, progress updates as the raise moves, and an annual report each year until it stops reporting. Every row here is one of those filings, linked to the filing itself, so each figure can be checked at the source. Figures are exactly as the company filed them; where a filing leaves a field blank, so does this page. Nothing here is investment advice, and a filing is the company's own statement, not a verification of it.